Healthy Investments Limited has notified the BSE of an upcoming Board of Directors meeting scheduled for Friday, February 22, 2026, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted by Director Krishna Babu Cherukuri on May 18, 2026, from the company's administrative office in Banjara Hills, Hyderabad.

Key Agenda Items

The board meeting has been convened to address several significant matters. The following table summarises the agenda items as disclosed in the regulatory filing:

Audited Financial Results

A primary item on the agenda is the consideration and approval of the audited financial results of the company for the fourth quarter and the full financial year ended March 31, 2026. The approval of these results is a standard regulatory requirement for listed companies and is expected to provide stakeholders with a comprehensive view of the company's financial performance for the period.

Promoter Reclassification

The board will also deliberate on the reclassification of a person belonging to the promoter category of the company to the public category. Such reclassifications are subject to SEBI guidelines and require board-level approval before being processed through the stock exchange.

Director Appointment

Another key agenda item is the appointment of Mr. Manish Kumar Shukla (DIN: 08520576) as an Additional Director in the category of Non-Executive Independent Director of the company. The induction of an independent director is a governance measure aimed at strengthening board composition in line with regulatory requirements.

The regulatory intimation was duly signed and submitted by Krishna Babu Cherukuri, Director (DIN: 00993286), on behalf of Healthy Investments Limited.

Healthy Investments Limited has submitted its quarterly compliance certificate to BSE Limited in accordance with SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The filing was made on April 14, 2026, ensuring timely regulatory compliance.

Quarterly Compliance Certificate Details

The certificate was issued by M/s. Venture Capital and Corporate Investments Private Limited, which serves as the company's Registrar and Share Transfer Agent (RTA). The document specifically addresses requirements under Regulation 74(5) of the SEBI regulations.

Securities Transaction Status

The certificate confirms that no securities were received for dematerialization or rematerialization during the Q4FY26 quarter. This indicates no conversion activity between physical and electronic form of shares occurred during this period.

Regulatory Framework

The filing falls under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly reporting by listed companies regarding their securities dematerialization activities. The certificate was digitally signed by Krishna Babu Cherukuri, Director of Healthy Investments Limited, with DIN: 00993286.

Company Information

Healthy Investments Limited maintains its administrative office at 1C, 1st Floor, Uma Enclave, Road No.9, Banjara Hills, Hyderabad – 500034. The company's securities are identified by scrip code 503689 on BSE Limited, with ISIN INE160N01017 for depositories tracking.